Manolete Partners
MANO · AIM · Financial Services · mcap £16m · 37.0p
- Revenue
- £27.9m
- Operating profit
- £2.7m
- Net income
- £1.1m
- Free cash flow
- £887k
- Net debt
- £11.5m
- Market cap
- £16.3m
- EV / EBIT
- 10.2×
- FCF yield
- +5.5%
- Price / book
- 0.4×
- Revenue
- £12.7m −12%
- Operating profit
- £91k −86%
- Net income
- −£476k prior −£218k
- Cash from operations
- £970k −15%
Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.
Every line as the company printed it, newest first – each period in the latest version the company published (restated figures where a later report restated them), in its own currency and units. Italic = calculated (H2 = full year − first half). The column headings link to the announcements.
Standardised line items in £m, comparable across companies; when a later report restated a period, the later figure is shown and marked r (hover for the figure first reported). Italic = calculated (LTM, H2 = FY − H1); a year of other than 12 months is marked (15m). Hover a value for its source.
Latest report: FY Mar 26 (twelve months to 31 Mar 26), published 25 Jun 26 · read the results ↗
| FY Mar 26'000 source | FY Mar 25'000 source | |
|---|---|---|
| Realised Revenue | 27,877 | 29,793 |
| Costs related to Realised Revenue | (17,457) | (20,159) |
| Gross Profit on Realised Cases | 10,420 | 9,634 |
| Gross Profit on Unrealised Cases | 2,735 | 1,006 |
| Gross Profit | 13,155 | 10,640 |
| Operating expenses | (10,423) | (7,463) |
| Operating profit | 2,732 | 3,177 |
| Finance income | 7 | 22 |
| Finance expense | (1,118) | (1,643) |
| Profit before tax | 1,621 | 1,556 |
| Analysed as | ||
| Adjusted Realised Profit Before Tax | 113 | 848 |
| Gross profit on unrealised cases | 2,735 | 1,006 |
| Adjusted Profit Before Tax | 2,848 | 1,854 |
| Adjusting items | (1,227) | (298) |
| Profit Before Tax | 1,621 | 1,556 |
| Taxation | (527) | (454) |
| Profit and total comprehensive income for the year | 1,094 | 1,102 |
| Earnings per share | ||
| Basic (pence per share) | 2.50p | 2.52p |
| Diluted (pence per share) | 2.46p | 2.48p |
| H2 Mar 26'000 calc. | H1 Sep 25'000 source | H2 Mar 25'000 calc. | H1 Sep 24'000 source | |
|---|---|---|---|---|
| Revenue | – | 12,715 | – | 14,402 |
| Cost of sales | – | (8,761) | – | (10,013) |
| Gross Profit | 9,201 | 3,954 | 6,251 | 4,389 |
| Administrative expenses | – | (3,863) | – | (3,731) |
| Operating Profit | 2,641 | 91 | 2,519 | 658 |
| Finance income | 1 | 6 | 6 | 16 |
| Finance expense | (363) | (755) | (784) | (859) |
| (Loss) / Profit before tax | 2,279 | (658) | 1,741 | (185) |
| Taxation | (709) | 182 | (421) | (33) |
| (Loss) / Profit and total comprehensive income for the period attributable to the equity owners of the Company | – | (476) | – | (218) |
| Basic (pence per share) | – | (1.09p) | – | (0.49p) |
| Diluted (pence per share) | – | (1.09p) | – | (0.49p) |
| 31 Mar 26'000 source | 31 Mar 25'000 source | |
|---|---|---|
| Non-current assets | ||
| Investments | 10,252 | 11,340 |
| Trade and other receivables | 12,026 | 11,486 |
| Deferred tax asset | 68 | 278 |
| Total non-current assets | 22,346 | 23,104 |
| Current assets | ||
| Investments | 35,708 | 30,110 |
| Trade and other receivables | 12,495 | 19,372 |
| Cash and cash equivalents | 1,247 | 692 |
| Total current assets | 49,450 | 50,174 |
| Total assets | 71,796 | 73,278 |
| EQUITY AND LIABILITIES | ||
| Equity | ||
| Share capital | 175 | 175 |
| Share premium | 157 | 157 |
| Share based payment reserve | 1,293 | 1,153 |
| Retained earnings | 40,777 | 39,565 |
| Total equity | 42,402 | 41,050 |
| Non-current liabilities | ||
| Trade and other payables | 6,771 | 7,271 |
| Borrowings | 12,745 | 11,762 |
| Total non-current liabilities | 19,516 | 19,033 |
| Current liabilities | ||
| Trade and other payables | 9,559 | 13,195 |
| Corporation tax payable | 319 | - |
| Total current liabilities | 9,878 | 13,195 |
| Total liabilities | 29,394 | 32,228 |
| Total equity and liabilities | 71,796 | 73,278 |
| 31 Mar 26'000 source | 30 Sep 25'000 source | 31 Mar 25'000 source | 30 Sep 24'000 source | |
|---|---|---|---|---|
| Non-current assets | ||||
| Investments | 10,252 | 10,143 | 11,340 | 11,291 |
| Trade and other receivables | 12,026 | 10,102 | 11,486 | 12,078 |
| Deferred tax asset | 68 | 497 | 278 | 1,093 |
| Total non-current assets | 22,346 | 20,742 | 23,104 | 24,462 |
| Current assets | ||||
| Investments | 35,708 | 30,151 | 30,110 | 28,251 |
| Trade and other receivables | 12,495 | 19,881 | 19,372 | 17,207 |
| Corporation tax asset | – | 98 | – | - |
| Cash and cash equivalents | 1,247 | 1,061 | 692 | 636 |
| Total current assets | 49,450 | 51,191 | 50,174 | 46,094 |
| Total assets | 71,796 | 71,933 | 73,278 | 70,556 |
| EQUITY AND LIABILITIES | ||||
| Equity | ||||
| Share capital | 175 | 175 | 175 | 175 |
| Share premium | 157 | 196 | 157 | 157 |
| Share based payment reserve | 1,293 | 1,189 | 1,153 | 1,351 |
| Retained earnings | 40,777 | 39,480 | 39,565 | 38,845 |
| Total equity attributable to the equity owners of the company | – | 41,040 | – | 40,528 |
| Total equity | 42,402 | – | 41,050 | – |
| Non-current liabilities | ||||
| Trade and other payables | 6,771 | 6,140 | 7,271 | 7,643 |
| Borrowings | 12,745 | 11,883 | 11,762 | 12,500 |
| Total non-current liabilities | 19,516 | 18,023 | 19,033 | 20,143 |
| Current liabilities | ||||
| Trade and other payables | 9,559 | 12,870 | 13,195 | 9,781 |
| Current tax liabilities | – | - | – | 104 |
| Corporation tax payable | 319 | – | - | – |
| Total current liabilities | 9,878 | 12,870 | 13,195 | 9,885 |
| Total liabilities | 29,394 | 30,893 | 32,228 | 30,028 |
| Total equity and liabilities | 71,796 | 71,933 | 73,278 | 70,556 |
| As at 1 April 2024 (unaudited) | – | 1,076 | – | 39,063 |
| Profit and total comprehensive loss | – | - | – | (218) |
| Share based payment expense | – | 191 | – | - |
| Deferred tax on share-based payments | – | 84 | – | - |
| As at 30 September 2024 (unaudited) | – | 1,351 | – | 38,845 |
| Profit and total comprehensive income | – | - | – | 1,111 |
| Share based payment expense | – | 92 | – | - |
| Deferred tax on share-based payments | – | (290) | – | - |
| As at 31 March 2025 (audited) | – | 1,153 | – | 39,956 |
| Loss and total comprehensive loss | – | - | – | (476) |
| Share based payment expense | – | (60) | – | - |
| Share options exercised | – | (39) | – | - |
| Deferred tax on share-based payments | – | 135 | – | - |
| As at 30 September 2025 (unaudited) | – | 1,189 | – | 39,480 |
| FY Mar 26'000 source | FY Mar 25'000 source | |
|---|---|---|
| Profit before tax | 1,621 | 1,556 |
| Adjustments for non-cash items | 4,037 | 7,515 |
| Operating cashflows before movements in working capital | 5,658 | 9,071 |
| Changes in working capital | ||
| Net decrease/(increase) in trade and other receivables | 6,337 | (2,602) |
| Net (decrease)/increase in trade and other payables | (3,933) | 2,924 |
| Net cash generated from operations before corporation tax and investments | 8,062 | 9,393 |
| Investment in cases | (7,175) | (6,865) |
| Net cash generated from operating activities | 887 | 2,528 |
| Cash flows from investing activities | ||
| Finance income received | 7 | 22 |
| Net cash generated from investing activities | 7 | 22 |
| Cash flows from financing activities | ||
| Proceeds from borrowings | 5,250 | 500 |
| Repayments of borrowings | (4,500) | (1,750) |
| Interest paid | (1,089) | (1,330) |
| Loan arrangement fees | - | (730) |
| Net cash used in financing activities | (339) | (3,310) |
| Net increase/(decrease) in cash and cash equivalents | 555 | (760) |
| Cash and cash equivalents at the beginning of the year | 692 | 1,452 |
| Cash and cash equivalents at the end of the year | 1,247 | 692 |
| H2 Mar 26'000 calc. | H1 Sep 25'000 source | H2 Mar 25'000 calc. | H1 Sep 24'000 source | |
|---|---|---|---|---|
| (Loss)/ Profit before tax | 2,279 | (658) | 1,741 | (185) |
| Adjustments for non-cash items | (763) | 4,800 | 2,522 | 4,993 |
| Operating cashflows before movements in working capital | 1,516 | 4,142 | 4,263 | 4,808 |
| Net (decrease) / increase in trade and other receivables | – | 1,579 | – | (5) |
| Net (decrease) / increase in trade and other payables | (2,137) | (1,796) | 3,279 | (355) |
| Net cash generated from operations before corporation tax and investment in cases | – | 3,925 | – | 4,448 |
| Corporation tax paid | – | - | – | - |
| Investment in cases | (4,220) | (2,955) | (3,559) | (3,306) |
| Net cash generated from operating activities | (83) | 970 | 1,386 | 1,142 |
| Finance income received | 1 | 6 | 6 | 16 |
| Net cash generated from investing activities | 1 | 6 | 6 | 16 |
| Proceeds from borrowings | 1,250 | 4,000 | - | 500 |
| Repayments of borrowings | (500) | (4,000) | - | (1,750) |
| Interest paid | (482) | (607) | (606) | (724) |
| Loan arrangement fees | - | - | (730) | - |
| Net cash used in financing activities | 268 | (607) | (1,336) | (1,974) |
| Net increase / (decrease) in cash and cash equivalents | 186 | 369 | 56 | (816) |
| Cash and cash equivalents at the beginning of the year | - | 692 | - | 1,452 |
| Cash and cash equivalents at the end of the period | – | 1,061 | – | 636 |
| FY Mar 26 | FY Mar 25 | |
|---|---|---|
| Revenue to operating profit | ||
| Revenue | 27.9 | 29.8r |
| Gross profit | 13.2 | 10.6r |
| Exceptional / adjusting items | (1.2) | (0.3) |
| Operating profit | 2.7 | 3.2r |
| Share-based payments | 0.3 | 0.3 |
| Operating profit to net income | ||
| Finance costs | (1.1) | (1.6) |
| Profit before tax | 1.6 | 1.6r |
| Tax | (0.5) | (0.5) |
| Net income (owners) | 1.1 | 1.1r |
| Per share | ||
| EPS basic | 2.5p | 2.5p |
| EPS diluted | 2.5p | 2.5p |
| H2 Mar 26 | H1 Sep 25 | H2 Mar 25 | H1 Sep 24 | |
|---|---|---|---|---|
| Revenue to operating profit | ||||
| Revenue | 15.2 | 12.7 | 15.4 | 14.4 |
| Gross profit | 9.2 | 4.0 | 6.3 | 4.4 |
| Operating profit | 2.6 | 0.1 | 2.5 | 0.7 |
| Share-based payments | 0.3 | (0.1) | 0.1 | 0.2 |
| Operating profit to net income | ||||
| Finance costs | (0.4) | (0.8) | (0.8) | (0.9) |
| Profit before tax | 2.3 | (0.7) | 1.7 | (0.2) |
| Tax | (0.7) | 0.2 | (0.4) | (0.0) |
| Net income (owners) | 1.6 | (0.5) | 1.3 | (0.2) |
| Per share | ||||
| EPS basic | 3.6p | (1.1p) | 3.0p | (0.5p) |
| EPS diluted | 3.6p | (1.1p) | 3.0p | (0.5p) |
| 31 Mar 26 | 31 Mar 25 | |
|---|---|---|
| Non-current assets | ||
| Non-current assets | 22.3 | 23.1 |
| Current assets | ||
| Trade receivables | 12.5 | 19.4 |
| Cash | 1.2 | 0.7 |
| Current assets | 49.5 | 50.2 |
| Total assets | 71.8 | 73.3r |
| Current liabilities | ||
| Trade payables | 9.6 | 13.2 |
| Current liabilities | 9.9 | 13.2 |
| Non-current liabilities | ||
| Borrowings, non-current | 12.7 | 11.8 |
| Non-current liabilities | 19.5 | 19.0 |
| Total liabilities | 29.4 | 32.2r |
| Equity | ||
| Total equity | 42.4 | 41.0r |
| Net cash and other figures | ||
| Net cash / (debt) ex leases | (11.5) | (11.1) |
| Net asset value | 42.4 | 41.0 |
| 31 Mar 26 | 30 Sep 25 | 31 Mar 25 | 30 Sep 24 | |
|---|---|---|---|---|
| Non-current assets | ||||
| Non-current assets | 22.3 | 20.7 | 23.1 | 24.5 |
| Current assets | ||||
| Trade receivables | 12.5 | – | 19.4 | – |
| Cash | 1.2 | 1.1 | 0.7 | 0.6 |
| Current assets | 49.5 | 51.2 | 50.2 | 46.1 |
| Total assets | 71.8 | 71.9 | 73.3r | 70.6 |
| Current liabilities | ||||
| Trade payables | 9.6 | – | 13.2 | – |
| Current liabilities | 9.9 | 12.9 | 13.2 | 9.9 |
| Non-current liabilities | ||||
| Borrowings, non-current | 12.7 | 11.9 | 11.8 | 12.5 |
| Non-current liabilities | 19.5 | 18.0 | 19.0 | 20.1 |
| Total liabilities | 29.4 | 30.9 | 32.2r | 30.0 |
| Equity | ||||
| Total equity | 42.4 | 41.0 | 41.0r | 40.5 |
| Net cash and other figures | ||||
| Net cash / (debt) ex leases | (11.5) | (10.8) | (11.1) | – |
| Net asset value | 42.4 | – | 41.0 | – |
| Undrawn facilities | – | 5.0 | – | – |
Read automatically from each results announcement. Check the source before relying on a figure.
Company filings. Not investment advice.